Laurence Nore
Advisory Board Member
Radiology
Applied Spectral Imaging
Israel
Biography
Most recently Laurence Nore was Director of Business Development at Ventana Medical Systems/Roche Diagnostics, the leader in tissue-based cancer diagnostics, where she led the collaboration with ASI as well as the acquisition of BioImagene. Prior to Ventana she was responsible for the launch of a Breast Cancer genetic test developed at Perlegen and developed the investment rationale for their Series E round. Laurence Nore also brings several years of experience in Therapeutics at Amgen and PDL BioPharma. She holds an MBA from the Anderson School at UCLA.
Research Interest
Most recently Laurence Nore was Director of Business Development at Ventana Medical Systems/Roche Diagnostics, the leader in tissue-based cancer diagnostics, where she led the collaboration with ASI as well as the acquisition of BioImagene. Prior to Ventana she was responsible for the launch of a Breast Cancer genetic test developed at Perlegen and developed the investment rationale for their Series E round. Laurence Nore also brings several years of experience in Therapeutics at Amgen and PDL BioPharma. She holds an MBA from the Anderson School at UCLA.
